Table 2 Main demographic and quality of life data (DLQI-BRA) according to each dermatosis (n = 1286)
From: Dimensionality and psychometric analysis of DLQI in a Brazilian population
Dermatosis | n (%) | Female (%) | Agea | Education level (%) | DLQI-BRAb | Â | ||
|---|---|---|---|---|---|---|---|---|
Elementary | High school | College | Cronbach’s alpha (CI 95%) | |||||
Melasma | 143 (11) | 123 (86) | 39 (8) | 19 (13) | 42 (29) | 82 (57) | 3 (1–6) | 0.89 (0.85–0.91) |
Urticaria | 101 (8) | 87 (86) | 42 (15) | 62 (61) | 35 (35) | 4 (4) | 14 (10–17) | 0.73 (0.64–0.80) |
Photoaging | 100 (8) | 64 (64) | 63 (7) | 69 (69) | 25 (25) | 6 (6) | 1 (0–4) | 0.72 (0.62–0.79) |
Genital Warts | 89 (7) | 0 (−) | 39 (14) | 39 (44) | 33 (37) | 17 (19) | 2 (0–4) | 0.73 (0.64–0.81) |
Bullous | 91 (7) | 56 (62) | 47 (15) | 70 (77) | 16 (18) | 5 (6) | 16 (9–20) | 0.81 (0.74–0.86) |
Onychocriptosis | 67 (5) | 41 (61) | 38 (17) | 13 (19) | 44 (66) | 10 (15) | 8 (5–12) | 0.77 (0.68–0.85) |
Uremic pruritus | 65 (5) | 24 (37) | 61 (13) | 35 (54) | 27 (42) | 3 (5) | 4 (2–7) | 0.84 (0.78–0.89) |
FPHLc | 76 (6) | 76 (100) | 47 (14) | 18 (24) | 13 (17) | 45 (59) | 6 (5–10) | 0.88 (0.84–0.92) |
Vitiligo | 96 (8) | 66 (69) | 46 (17) | 33 (34) | 37 (39) | 26 (27) | 3 (1–7) | 0.87 (0.82–0.90) |
Psoriasis | 135 (11) | 62 (46) | 51 (14) | 68 (50) | 44 (33) | 23 (17) | 3 (1–8) | 0.91 (0.90–0.93) |
Leprosy | 92 (7) | 31 (34) | 51 (14) | 75 (82) | 15 (16) | 2 (2) | 3 (2–7) | 0.89 (0.85–0.92) |
Rosacea | 72 (6) | 59 (82) | 45 (12) | 17 (24) | 20 (28) | 35 (49) | 5 (2–8) | 0.85 (0.79–0.90) |
BCCd | 70 (5) | 35 (50) | 63 (11) | 54 (77) | 14 (20) | 2 (3) | 1 (1–3) | 0.79 (0.70–0.85) |
Hidradenitis | 89 (7) | 43 (48) | 31 (13) | 17 (19) | 49 (55) | 23 (26) | 19 (12–25) | 0.91 (0.88–0.93) |
TOTAL | 1286 (100) | 767 (60) | 47 (16) | 589 (46) | 414 (32) | 283 (22) | 5 (2–11) | 0.90 (0.89–0.91) |